Journal
NANOMATERIALS
Volume 8, Issue 4, Pages -Publisher
MDPI
DOI: 10.3390/nano8040268
Keywords
ZnO nanoparticles; Quantum dots; theranostic; drug delivery; anti-tumour; diabetes treatment; anti-inflammation; antibacterial; antifungal; wound healing
Categories
Funding
- European Research Council, ERC-AdG (VERDI) [694160]
- Ministerio de Economia y Competitividad (MINECO) [MAT2015-64831-R]
- Irish Research Council
- European Research Council (ERC) [694160] Funding Source: European Research Council (ERC)
Ask authors/readers for more resources
In the last two decades, zinc oxide (ZnO) semiconductor Quantum dots (QDs) have been shown to have fantastic luminescent properties, which together with their low-cost, low-toxicity and biocompatibility have turned these nanomaterials into one of the main candidates for bio-imaging. The discovery of other desirable traits such as their ability to produce destructive reactive oxygen species (ROS), high catalytic efficiency, strong adsorption capability and high isoelectric point, also make them promising nanomaterials for therapeutic and diagnostic functions. Herein, we review the recent progress on the use of ZnO based nanoplatforms in drug delivery and theranostic in several diseases such as bacterial infection and cancer.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available